Baseline Characteristics in Part 2 of “ - PDF Document
Baseline Characteristics in Part 2 of “ MOXIe ” Trial: A Study of the Efficacy and Safety of Omaveloxolone in Patients with Friedreich’s Ataxia. S.H. Subramony, MD; Sylvia Boesch, MD; Melanie Chin, PhD; Martin B. Delatycki, MD; Jennifer Farmer, MS; Paola Giunti,
Uploaded on |
0 Views
